Answers are grounded in this paper and cite their sources.
AXT107 also reduced total VEGFR2 levels by increasing internalization, ubiquitination, and degradation. This biomimetic peptide is a sustained, multitargeted therapy that may provide advantages over intraocular injections of specific VEGF-neutralizing proteins.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: